Omega Healthcare Investors Inc (NYSE:OHI) was the target of some unusual options trading on Monday. Investors acquired 9,759 call options on the company. This represents an increase of approximately 2,422% compared to the typical volume of 387 call options.
In other news, insider Michael Ritz sold 6,000 shares of the firm’s stock in a transaction on Friday, November 16th. The stock was sold at an average price of $34.75, for a total value of $208,500.00. Following the completion of the transaction, the insider now owns 10,076 shares in the company, valued at $350,141. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 1.65% of the company’s stock.
A number of large investors have recently modified their holdings of OHI. Daiwa Securities Group Inc. boosted its stake in Omega Healthcare Investors by 43.9% in the 2nd quarter. Daiwa Securities Group Inc. now owns 5,032,761 shares of the real estate investment trust’s stock worth $156,015,000 after buying an additional 1,536,523 shares during the last quarter. Scout Investments Inc. boosted its stake in Omega Healthcare Investors by 355.2% in the 2nd quarter. Scout Investments Inc. now owns 1,130,335 shares of the real estate investment trust’s stock worth $35,040,000 after buying an additional 882,039 shares during the last quarter. Cornerstone Wealth Management LLC boosted its stake in Omega Healthcare Investors by 3,000.0% in the 2nd quarter. Cornerstone Wealth Management LLC now owns 909,261 shares of the real estate investment trust’s stock worth $29,331,000 after buying an additional 879,930 shares during the last quarter. First Republic Investment Management Inc. raised its holdings in shares of Omega Healthcare Investors by 2,344.6% in the 2nd quarter. First Republic Investment Management Inc. now owns 881,585 shares of the real estate investment trust’s stock worth $27,329,000 after purchasing an additional 845,523 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in shares of Omega Healthcare Investors by 14.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,689,457 shares of the real estate investment trust’s stock worth $176,373,000 after purchasing an additional 736,393 shares during the period. 73.10% of the stock is currently owned by hedge funds and other institutional investors.
NYSE:OHI traded down $0.20 during mid-day trading on Thursday, reaching $36.28. The company’s stock had a trading volume of 1,491,572 shares, compared to its average volume of 2,610,212. The company has a current ratio of 4.17, a quick ratio of 4.17 and a debt-to-equity ratio of 1.21. Omega Healthcare Investors has a twelve month low of $24.90 and a twelve month high of $36.54. The firm has a market cap of $7.32 billion, a price-to-earnings ratio of 10.99, a PEG ratio of 7.07 and a beta of 0.13.
Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Monday, November 5th. The real estate investment trust reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.46). Omega Healthcare Investors had a return on equity of 7.32% and a net margin of 31.91%. The business had revenue of $192.30 million during the quarter, compared to analyst estimates of $194.40 million. During the same period in the previous year, the business posted $0.79 earnings per share. The firm’s quarterly revenue was down .9% on a year-over-year basis. As a group, research analysts forecast that Omega Healthcare Investors will post 2.97 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Thursday, November 15th. Shareholders of record on Wednesday, October 31st were paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 7.28%. The ex-dividend date was Tuesday, October 30th. Omega Healthcare Investors’s payout ratio is 80.00%.
A number of analysts recently commented on OHI shares. Stifel Nicolaus increased their price objective on Omega Healthcare Investors from $27.00 to $30.00 and gave the company a “hold” rating in a research note on Tuesday, August 7th. MED started coverage on Omega Healthcare Investors in a research note on Tuesday, October 2nd. They set a “neutral” rating and a $31.00 price objective on the stock. They noted that the move was a valuation call. ValuEngine raised Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Monday, August 13th. Bank of America raised Omega Healthcare Investors from an “underperform” rating to a “neutral” rating and set a $35.00 price objective on the stock in a research note on Friday, November 16th. Finally, Mitsubishi UFJ Financial Group reaffirmed a “neutral” rating on shares of Omega Healthcare Investors in a research note on Tuesday, October 2nd. Eight equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $32.50.
TRADEMARK VIOLATION NOTICE: This news story was originally posted by Enterprise Leader and is the sole property of of Enterprise Leader. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://theenterpriseleader.com/2018/11/22/omega-healthcare-investors-sees-unusually-high-options-volume-ohi.html.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Article: How can you know how many shares are floating?
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.